1982年，艾伦患上霍奇金淋巴瘤。
这个淋巴结与霍奇金淋巴瘤有关。
今年早些时候，迈克尔刚完成了霍奇金淋巴瘤的治疗。
Michael also completed treatment for Hodgkin's lymphoma earlier this year.
最常见死因是非霍奇金淋巴瘤进展（74％）。
霍奇金淋巴瘤的分期对治疗和预后都很重要。
Staging of Hodgkin's disease is important to try and determine therapy and the prognosis.
我的双胞胎哥哥被确诊为三期非霍奇金淋巴瘤。
My twin brother was diagnosed with stage three non Hodgkin's lymphoma.
霍奇金淋巴瘤中白细胞计数升高并不是其特征。
Hodgkin lymphoma is not characterized by an increased WBC count.
可见大的蓝色的非霍奇金淋巴瘤细胞浸润黏膜层。
The large blue non-Hodgkin's lymphoma cells can be seen infiltrating through the mucosa.
霍奇金淋巴瘤是淋巴结上的肿瘤，淋巴结是免疫系统的一部分。
Hodgkin's lymphoma is the cancer of the lymph nodes, which are part of the immune system.
放射治疗也可用于在某些情况下，非霍奇金淋巴瘤。
Radiotherapy may also be used in some cases of Non Hodgkin lymphoma.
目的：研究复发性中高度非霍奇金淋巴瘤的解救治疗。
Purpose: To study the salvage treatment of recurrent intermediate-high grade non Hodgkin lymphoma (NHL).
目的探讨胃肠道非霍奇金淋巴瘤(NHL)的治疗方法。
Objective To investigate an effective therapy for gastrointestinal non - Hodgkin lymphoma (NHL).
CTCL的是一种非霍奇金淋巴瘤，这是一种免疫系统癌症。
CTCL is a type of non-Hodgkin's lymphoma, which is a cancer of the immune system.
目的观察bvmap方案治疗难治性非霍奇金淋巴瘤的疗效。
Objective to observe the effect of BVMAP regimen in treatment of refractory Non Hodgkin's lymphoma.
研究复发性、难治性中高度恶性非霍奇金淋巴瘤的解救治疗。
To study the salvage treatment of relapsed or refractory intermediate-high aggressive non-Hodgkin lymphoma (NHL).
几乎全部都是非霍奇金淋巴瘤，而且绝大部分为B细胞淋巴瘤。
It is always the non-Hodgkin type, and the vast majority are B-cell lymphomas.
研究发现，CD 4细胞计数是霍奇金淋巴瘤，肺癌和肝癌的唯一的风险因素。
CD4 count was the only risk factor for Hodgkin's lymphoma, lung cancer and liver cancer, the study found.
本文就近年来环境因素在非霍奇金淋巴瘤病因中作用的研究进展作一综述。
This paper reviewed the research advance on the role of environmental factors in the etiology of non-Hodgkin lymphoma.
淋巴瘤，包括霍奇金淋巴瘤，是一个淋巴细胞的DNA获得性损伤造成的。
Lymphomas, including Hodgkin lymphoma, result from an acquired injury to the DNA of a lymphocyte.
目的探讨STAT3的活化对霍奇金淋巴瘤(HL)细胞凋亡的调控作用。
Objective to investigate regulation of activated STAT3 on apoptosis of Hodgkin's lymphoma (HL) cells.
目的：观察IP方案治疗复发和难治性非霍奇金淋巴瘤的疗效和毒性反应。
Objective: to observe the effect and side effects of IP regimen for patients with recurrent and refractory Non-Hodgkin's lymphoma.
淋巴瘤可分为两大类：霍奇金淋巴瘤和其他的淋巴瘤，被称作非霍奇金淋巴瘤。
The lymphomas are divided into two major categories: Hodgkin lymphoma and all other lymphomas, called non-Hodgkin lymphomas.
目的探讨原发性胃肠道非霍奇金淋巴瘤(PGI - NHL)的诊断及治疗。
Objective To explore the diagnosis and treatment of primary gastrointestinal non-Hodgkin's lymphoma (PGI-NHL).
目的：认识儿童非霍奇金淋巴瘤(NHL)及白血病肾脏浸润的各种CT表现。
Purpose: To understand the various CT findings of renal involvement of non-Hodgkin lymphoma (NHL) and leukemia in children.
目的探讨骨原发性非霍奇金淋巴瘤的影像学特性，着重分析其MRI信号表现。
Objective To study the imaging features of primary bone non-Hodgkin lymphoma with an emphasis on MRI signal characteristics.
目的评价CHEP和CHOP方案治疗非霍奇金淋巴瘤(NHL)的疗效和毒性。
Objective Therapeutic effect and toxicity of CHEP and CHOP chemotherapy in the treatment of non Hodgkin's lymphoma (NHL) were compared.
Rituxan现在已经被批准用于非霍奇金淋巴瘤、慢性淋巴细胞白血病和风湿性关节炎的治疗。
Rituxan is currently approved as a treatment for non-Hodgkin's lymphoma, chronic lymphocytic leukemia and rheumatoid arthritis.
滤泡性B细胞淋巴瘤是一种非霍奇金淋巴瘤，肿瘤疫苗是治疗是根据肿瘤细胞的生物学特殊性。
The cancer vaccines rely on a biological quirk of follicular B-cell lymphoma, which is a type of non-Hodgkin's lymphoma.
非霍奇金淋巴瘤的死亡率比霍奇金淋巴瘤高，预测2010年美国死于该病症的人数将超过20 000。
Non-Hodgkin lymphoma is deadlier than Hodgkin lymphoma, and is expected to kill more than 20, 000 people in 2010.
非霍奇金淋巴瘤的死亡率比霍奇金淋巴瘤高，预测2010年美国死于该病症的人数将超过20 000。
Non-Hodgkin lymphoma is deadlier than Hodgkin lymphoma, and is expected to kill more than 20, 000 people in 2010.
应用推荐